Arkema SA (OTCMKTS:ARKAY – Get Free Report) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 1,412 shares, a decline of 83.6% from the November 30th total of 8,603 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 28,506 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 28,506 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
Wall Street Analysts Forecast Growth
ARKAY has been the topic of several recent analyst reports. Citigroup reiterated a “buy” rating on shares of Arkema in a research note on Friday, October 3rd. Zacks Research upgraded Arkema from a “strong sell” rating to a “hold” rating in a research note on Monday, December 8th. Barclays downgraded shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Arkema from a “buy” rating to a “hold” rating in a report on Monday, November 24th. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Arkema has an average rating of “Reduce”.
Check Out Our Latest Research Report on Arkema
Arkema Trading Down 0.1%
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings results on Friday, November 7th. The basic materials company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.21. The company had revenue of $2.52 billion during the quarter, compared to analysts’ expectations of $2.50 billion. Arkema had a net margin of 1.55% and a return on equity of 5.15%. Equities research analysts predict that Arkema will post 8.36 EPS for the current year.
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
See Also
- Five stocks we like better than Arkema
- Washington prepares for war
- Turn your “dead money” into $306+ monthly (starting this month)
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
